Inside story: How Chinese biopharma firm WuXi will target European market from its €1 billion Dundalk campus
In what marks a first major foreign direct investment by a Chinese multinational in this country, WuXi has built one of the largest biopharma campuses in the world where it plans to produce 50 million vaccine doses a year – the Business Post